Patent · US Expired

Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)

US7262207B2 · kind B2 · utility

6Cited by
5References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 27, 2004
Grant dateAug 28, 2007
Priority date
Expiry dateSep 15, 2024

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/12
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, Syndrome X, hyperinsulinemia, obesity, atherosclerosis, and various immunomodulatory diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.